Cytosorbents
CTSO
#9418
Rank
โ‚น4.27 B
Marketcap
โ‚น77.71
Share price
3.99%
Change (1 day)
-46.89%
Change (1 year)

Revenue for Cytosorbents (CTSO)

Revenue in 2024 (TTM): โ‚น2.81 Billion

According to Cytosorbents's latest financial reports the company's current revenue (TTM ) is โ‚น2.86 Billion. In 2023 the company made a revenue of โ‚น2.58 Billion an increase over the revenue in the year 2022 that were of โ‚น2.42 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Cytosorbents from 2009 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚น2.81 B8.95%
2023 โ‚น2.58 B6.51%
2022 โ‚น2.42 B-18.62%
2021 โ‚น2.98 B3.47%
2020 โ‚น2.88 B77.73%
2019 โ‚น1.62 B14.64%
2018 โ‚น1.41 B65.73%
2017 โ‚น0.85 B53.22%
2016 โ‚น0.55 B106.9%
2015 โ‚น0.26 B35.24%
2014 โ‚น0.19 B292.55%
2013 โ‚น50.77 M-277.15%
2012 -โ‚น28.66 Million-1601.64%
2011 โ‚น1.9 M
2010 N/A
2009 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚น28.28 B 885.48%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น342.28 B 11,826.58%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1.351 T 46,981.33%๐Ÿ‡บ๐Ÿ‡ธ USA